ESR1 and breast carcinoma: Indeed, synthetic and natural ligands of LXRs, e.g., T0901317 and 22(R)-hydroxycholesterol (22(R)-OHC), both suppressed proliferation and induced apoptosis in a breast cancer model cell line (ER+) [8].